Shridhar, D. R.; Rao, K. Srinivasa; Bhopale, K.K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1980, vol. 19, # 8, p. 699 - 701
Structure and activity relationships of novel uracil derivatives as topical anti-inflammatory agents
摘要:
In order to create novel, topical anti-inflammatory compounds exhibiting more potent activities than lead compound CX-659S (1), we designed and synthesized various derivatives of 1 focusing on the uracil N(l)- and N(3)-substituents, and evaluated their anti-inflammatory activities via inhibition of the picryl chloride-induced contact hypersensitivity reaction (CHR) in mice. In the course of our structure and activity relationship study, we found that compounds 6k, 6q, and 6r inhibited by approximately 50% the CHR, at 0.1 mg/ear. These activities were essentially equipotent with that of Tacrolimus, a strong immunosuppressant. (C) 2003 Elsevier Ltd. All rights reserved.
SHRIDHAR D. R.; RAO K. S.; BHOPALE K. K.; TRIPATHI H. N.; SAI G. S. T., INDIAN J. CHEM., 1980, B19, NO 8, 699-701
作者:SHRIDHAR D. R.、 RAO K. S.、 BHOPALE K. K.、 TRIPATHI H. N.、 SAI G. S. T.
DOI:——
日期:——
Shridhar, D. R.; Rao, K. Srinivasa; Bhopale, K.K., Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1980, vol. 19, # 8, p. 699 - 701
作者:Shridhar, D. R.、Rao, K. Srinivasa、Bhopale, K.K.、Tripathi, H. N.、Sai, G. S. T.
DOI:——
日期:——
Structure and activity relationships of novel uracil derivatives as topical anti-inflammatory agents
In order to create novel, topical anti-inflammatory compounds exhibiting more potent activities than lead compound CX-659S (1), we designed and synthesized various derivatives of 1 focusing on the uracil N(l)- and N(3)-substituents, and evaluated their anti-inflammatory activities via inhibition of the picryl chloride-induced contact hypersensitivity reaction (CHR) in mice. In the course of our structure and activity relationship study, we found that compounds 6k, 6q, and 6r inhibited by approximately 50% the CHR, at 0.1 mg/ear. These activities were essentially equipotent with that of Tacrolimus, a strong immunosuppressant. (C) 2003 Elsevier Ltd. All rights reserved.